Once again, with the majority of brokers across Australia taking a well-earned break, broker notes will be few and far between until next week.
In light of this, listed below are a few recent broker recommendations that remain very relevant today. Here are three ASX shares rated as buys:
Appen Ltd (ASX: APX)
According to a note out of Citi, its analysts have a buy rating and $17.10 price target on this artificial intelligence data services company’s shares. Although Citi notes that Amazon’s entry into the fully managed data labelling service market could increase competition in the Enterprise space, it doesn’t expect it to impact Appen’s relationships with major tech companies. The broker also highlights that Amazon’s move is a sign that Appen’s services remain in demand with end users despite concerns about self-learning systems. The Appen share price is currently trading at $10.13.
CSL Limited (ASX: CSL)
A note out of Morgans reveals that its analysts have an add rating and $334.70 price target on this biotherapeutics giant’s shares. The broker was pleased with the acquisition of Vifor Pharma for $17 billion and believes it will complement its existing business and provide growth opportunities. Morgans also doesn’t believe the acquisition is being undertaken because CSL’s core plasma business’ growth is over. The CSL share price is fetching $283.60 on Thursday.
De Grey Mining Limited (ASX: DEG)
Analysts at Macquarie have put an outperform rating and $1.70 price target on this gold developer’s shares. Macquarie is a fan of De Grey Mining partly due to its Mallina gold project. The broker believes this project has tier-1 potential and could support upwards of 15 years of production. Macquarie expects production to commence in FY 2026 and generate significant free cash flow each year. The De Grey share price is trading at $1.14 today.
The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of August 16th 2021
More reading
- Why did Pro Medicus (ASX:PME) and 2 other ASX 200 healthcare shares fall today?
- Why the Appen (ASX:APX) share price crashed 55% lower in 2021
- 5 things to watch on the ASX 200 on Wednesday
- Leading brokers name 3 ASX shares to buy
- Here are the 5 best performing ASX biotech shares of 2021
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Appen Ltd and CSL Ltd. The Motley Fool Australia owns and has recommended Appen Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/3t2lpO3
Leave a Reply